Development of Small-Molecule Inhibitors Against Zika Virus Infection

38Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

Abstract

In recent years, the outbreak of infectious disease caused by Zika virus (ZIKV) has posed a major threat to global public health, calling for the development of therapeutics to treat ZIKV disease. Here, we have described the different stages of the ZIKV life cycle and summarized the latest progress in the development of small-molecule inhibitors against ZIKV infection. We have also discussed some general strategies for the discovery of small-molecule ZIKV inhibitors.

Cite

CITATION STYLE

APA

Wang, L., Liang, R., Gao, Y., Li, Y., Deng, X., Xiang, R., … Yu, F. (2019, December 6). Development of Small-Molecule Inhibitors Against Zika Virus Infection. Frontiers in Microbiology. Frontiers Media S.A. https://doi.org/10.3389/fmicb.2019.02725

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free